HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lui, K J Articles by Kendal, A P Search for Related Content PubMed PubMed Citation Articles by Lui, K J Articles by Kendal, A P

Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985.

K J Lui and A P Kendal

Baseline levels of mortality in the United States in the absence of influenza epidemics were estimated using cyclical regression models applied to national vital statistics from October 1972 to May 1985. Models were developed by age and by region. Results from 1983 to 1985 are preliminary. More mortality than predicted by the theoretical baseline occurred during nine influenza seasons. Epidemics with high morbidity in children and young adults occurred in 1976/77 and 1978/79. Regional differences in the impact of influenza occurred occasionally. Total influenza-associated excess mortality in six epidemics from the winters of 1972/73 to 1980/81 was about 200,000. About 80-90 per cent of excess mortality occurred in persons over 64 years old.

This article has been cited by other articles:

				M. M. Davis, K. Taubert, A. L. Benin, D. W. Brown, G. A. Mensah, L. M. Baddour, S. Dunbar, and H. M. Krumholz Influenza Vaccination as Secondary Prevention for Cardiovascular Disease: A Science Advisory From the American Heart Association/American College of Cardiology J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1498 - 1502. [Abstract] [Full Text] [PDF]

				M. M. Davis, K. Taubert, A. L. Benin, D. W. Brown, G. A. Mensah, L. M. Baddour, S. Dunbar, and H. M. Krumholz Influenza Vaccination as Secondary Prevention for Cardiovascular Disease: A Science Advisory From the American Heart Association/American College of Cardiology: Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Association of Critical Care Nurses, the American Association of Heart Failure Nurses, the American Diabetes Association, the Association of Black Cardiologists, Inc., the Heart Failure Society of America, and the Preventive Cardiovascular Nurses Association.: The American Academy of Nurse Practitioners supports the recommendations of this scientific advisory.: This science advisory is consistent with the recommendations of the Centers for Disease Control and Prevention and the Advisory Committee on Immunization Practices. Circulation, October 3, 2006; 114(14): 1549 - 1553. [Abstract] [Full Text] [PDF]

				S. K. Greene, E. L. Ionides, and M. L. Wilson Patterns of Influenza-associated Mortality among US Elderly by Geographic Region and Virus Subtype, 1968-1998 Am. J. Epidemiol., February 15, 2006; 163(4): 316 - 326. [Abstract] [Full Text] [PDF]

				D. R. Olson, L. Simonsen, P. J. Edelson, and S. S. Morse Epidemiological evidence of an early wave of the 1918 influenza pandemic in New York City PNAS, August 2, 2005; 102(31): 11059 - 11063. [Abstract] [Full Text] [PDF]

				L. Simonsen, T. A. Reichert, C. Viboud, W. C. Blackwelder, R. J. Taylor, and M. A. Miller Impact of Influenza Vaccination on Seasonal Mortality in the US Elderly Population Arch Intern Med, February 14, 2005; 165(3): 265 - 272. [Abstract] [Full Text] [PDF]

				A. D. Heymann, Y. Shapiro, G. Chodick, V. Shalev, E. Kokia, E. Kramer, and J. Shemer Reduced Hospitalizations and Death Associated With Influenza Vaccination Among Patients With and Without Diabetes Diabetes Care, November 1, 2004; 27(11): 2581 - 2584. [Abstract] [Full Text] [PDF]

				T. A. Reichert, L. Simonsen, A. Sharma, S. A. Pardo, D. S. Fedson, and M. A. Miller Influenza and the Winter Increase in Mortality in the United States, 1959-1999 Am. J. Epidemiol., September 1, 2004; 160(5): 492 - 502. [Abstract] [Full Text] [PDF]

				C. T. Pachucki, M. A. Khurshid, and J. Nawrocki Utility of Reverse Transcriptase PCR for Rapid Diagnosis of Influenza A Virus Infection and Detection of Amantadine-Resistant Influenza A Virus Isolates J. Clin. Microbiol., June 1, 2004; 42(6): 2796 - 2798. [Abstract] [Full Text] [PDF]

				E. S. Ford, D. M. Mannino, and S. G. Williams Asthma and Influenza Vaccination: Findings From the 1999-2001 National Health Interview Surveys Chest, September 1, 2003; 124(3): 783 - 789. [Abstract] [Full Text] [PDF]

				F.-C. Tsui, M. M. Wagner, V. Dato, and C.-C. H. Chang Value of ICD-9-Coded Chief Complaints for Detection of Epidemics J. Am. Med. Inform. Assoc., November 1, 2002; 9(90061): S41 - 47. [Abstract] [Full Text] [PDF]

				V. H. Menec, L. MacWilliam, and F. Y. Aoki Hospitalizations and Deaths Due to Respiratory Illnesses During Influenza Seasons: A Comparison of Community Residents, Senior Housing Residents, and Nursing Home Residents J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2002; 57(10): M629 - 635. [Abstract] [Full Text] [PDF]

				F. Carrat, C. Sahler, S. Rogez, M. Leruez-Ville, F. Freymuth, C. Le Gales, M. Bungener, B. Housset, M. Nicolas, and C. Rouzioux Influenza Burden of Illness: Estimates From a National Prospective Survey of Household Contacts in France Arch Intern Med, September 9, 2002; 162(16): 1842 - 1848. [Abstract] [Full Text] [PDF]

				P. Y. Lee, D. B. Matchar, D. A. Clements, J. Huber, J. D. Hamilton, and E. D. Peterson Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults Ann Intern Med, August 20, 2002; 137(4): 225 - 231. [Abstract] [Full Text] [PDF]

				J.-P. Humair, C. R. Buchs, and H. Stalder Promoting influenza vaccination of elderly patients in primary care Fam. Pract., August 1, 2002; 19(4): 383 - 389. [Abstract] [Full Text] [PDF]

				Y. Deguchi and K. Nishimura Efficacy of Influenza Vaccine in Elderly Persons in Welfare Nursing Homes: Reduction in Risks of Mortality and Morbidity During an Influenza A (H3N2) Epidemic J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2001; 56(6): M391 - M394. [Abstract] [Full Text] [PDF]

				L. M. Hodge, M. Marinaro, H. P. Jones, J. R. McGhee, H. Kiyono, and J. W. Simecka Immunoglobulin A (IgA) Responses and IgE-Associated Inflammation along the Respiratory Tract after Mucosal but Not Systemic Immunization Infect. Immun., April 1, 2001; 69(4): 2328 - 2338. [Abstract] [Full Text] [PDF]

				T. A. Reichert, N. Sugaya, D. S. Fedson, W. P. Glezen, L. Simonsen, and M. Tashiro The Japanese Experience with Vaccinating Schoolchildren against Influenza N. Engl. J. Med., March 22, 2001; 344(12): 889 - 896. [Abstract] [Full Text] [PDF]

				K. L. Nichol Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza Arch Intern Med, March 12, 2001; 161(5): 749 - 759. [Abstract] [Full Text] [PDF]

				D. F. Smee, J. H. Huffman, A. C. Morrison, D. L. Barnard, and R. W. Sidwell Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities Antimicrob. Agents Chemother., March 1, 2001; 45(3): 743 - 748. [Abstract] [Full Text]

				A. Cifu and W. Levinson Influenza JAMA, December 13, 2000; 284(22): 2847 - 2849. [Full Text] [PDF]

				Flu Season 2000-01: Calling the Shots Journal Watch Women's Health, September 5, 2000; 2000(905): 13 - 13. [Full Text]

				Y. DEGUCHI, Y. TAKASUGI, and K. TATARA Efficacy of influenza vaccine in the elderly in welfare nursing homes: reduction in risks of mortality and morbidity during an influenza A (H3N2) epidemic J. Med. Microbiol., June 1, 2000; 49(6): 553 - 556. [Abstract] [Full Text] [PDF]

				R. P. Wenzel Expanding the Treatment Options for Influenza JAMA, February 23, 2000; 283(8): 1057 - 1059. [Full Text] [PDF]

				K. L. Nichol, L. Baken, and A. Nelson Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung Disease Ann Intern Med, March 2, 1999; 130(5): 397 - 403. [Abstract] [Full Text] [PDF]

				P. C. Tang, M. P. LaRosa, C. Newcomb, and S. M. Gorden Measuring the Effects of Reminders for Outpatient Influenza Immunizations at the Point of Clinical Opportunity J. Am. Med. Inform. Assoc., March 1, 1999; 6(2): 115 - 121. [Abstract] [Full Text] [PDF]

				R. Sarnoff and T. Rundall Meta-Analysis of Effectiveness of Interventions to Increase Influenza Immunization Rates among High-Risk Population Groups Med Care Res Rev, December 1, 1998; 55(4): 432 - 456. [Abstract] [PDF]

				K. L. Nichol, J. Wuorenma, and T. von Sternberg Benefits of Influenza Vaccination for Low-, Intermediate-, and High-Risk Senior Citizens Arch Intern Med, September 14, 1998; 158(16): 1769 - 1776. [Abstract] [Full Text] [PDF]

				W. H. Barker, H. Borisute, and C. Cox A Study of the Impact of Influenza on the Functional Status of Frail Older People Arch Intern Med, March 23, 1998; 158(6): 645 - 650. [Abstract] [Full Text] [PDF]

				D. B. Mendel, C. Y. Tai, P. A. Escarpe, W. Li, R. W. Sidwell, J. H. Huffman, C. Sweet, K. J. Jakeman, J. Merson, S. A. Lacy, et al. Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection Antimicrob. Agents Chemother., March 1, 1998; 42(3): 640 - 646. [Abstract] [Full Text]

				W. Li, P. A. Escarpe, E. J. Eisenberg, K. C. Cundy, C. Sweet, K. J. Jakeman, J. Merson, W. Lew, M. Williams, L. Zhang, et al. Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Antimicrob. Agents Chemother., March 1, 1998; 42(3): 647 - 653. [Abstract] [Full Text]

				K. L. Nichol, A. Lind, K. L. Margolis, M. Murdoch, R. McFadden, M. Hauge, S. Magnan, and M. Drake The Effectiveness of Vaccination against Influenza in Healthy, Working Adults N. Engl. J. Med., October 5, 1995; 333(14): 889 - 893. [Abstract] [Full Text] [PDF]

				K.L. Nichol, K.L. Margolis, J. Wuorenma, and T. Von Sternberg The Efficacy and Cost Effectiveness of Vaccination against Influenza among Elderly Persons Living in the Community N. Engl. J. Med., September 22, 1994; 331(12): 778 - 784. [Abstract] [Full Text]